Literature DB >> 23222788

An mRNA vaccine for influenza.

Sook-San Wong1, Richard J Webby.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23222788     DOI： 10.1038/nbt.2439

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

1.  In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.

Authors:  I Hoerr; R Obst; H G Rammensee; G Jung
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

Review 2.  RNA-based vaccines.

Authors:  Jeffrey B Ulmer; Peter W Mason; Andrew Geall; Christian W Mandl
Journal:  Vaccine       Date:  2012-04-28       Impact factor: 3.641

Review 3.  Recent advances in Ebolavirus vaccine development.

Authors:  Jason S Richardson; Joseph D Dekker; Maria A Croyle; Gary P Kobinger
Journal:  Hum Vaccin       Date:  2010-06-01

4.  Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.

Authors:  Melissa B Pearce; Jessica A Belser; Katherine V Houser; Jacqueline M Katz; Terrence M Tumpey
Journal:  Vaccine       Date:  2011-02-21       Impact factor: 3.641

5.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

6.  Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.

Authors:  Benjamin Petsch; Margit Schnee; Annette B Vogel; Elke Lange; Bernd Hoffmann; Daniel Voss; Thomas Schlake; Andreas Thess; Karl-Josef Kallen; Lothar Stitz; Thomas Kramps
Journal:  Nat Biotechnol       Date:  2012-11-25       Impact factor: 54.908

Review 7.  Seasonal influenza vaccines.

Authors:  Anthony E Fiore; Carolyn B Bridges; Nancy J Cox
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

8.  Cross-neutralization of influenza A viruses mediated by a single antibody loop.

Authors:  Damian C Ekiert; Arun K Kashyap; John Steel; Adam Rubrum; Gira Bhabha; Reza Khayat; Jeong Hyun Lee; Michael A Dillon; Ryann E O'Neil; Aleksandr M Faynboym; Michael Horowitz; Lawrence Horowitz; Andrew B Ward; Peter Palese; Richard Webby; Richard A Lerner; Ramesh R Bhatt; Ian A Wilson
Journal:  Nature       Date:  2012-09-16       Impact factor: 49.962

9.  Avian flu: influenza virus receptors in the human airway.

Authors:  Kyoko Shinya; Masahito Ebina; Shinya Yamada; Masao Ono; Noriyuki Kasai; Yoshihiro Kawaoka
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

10.  Cross-reacting antibodies enhance dengue virus infection in humans.

Authors:  Wanwisa Dejnirattisai; Amonrat Jumnainsong; Naruthai Onsirisakul; Patricia Fitton; Sirijitt Vasanawathana; Wannee Limpitikul; Chunya Puttikhunt; Carolyn Edwards; Thaneeya Duangchinda; Sunpetchuda Supasa; Kriangkrai Chawansuntati; Prida Malasit; Juthathip Mongkolsapaya; Gavin Screaton
Journal:  Science       Date:  2010-05-07       Impact factor: 47.728
  10 in total
  8 in total

1.  Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.

Authors:  Savan K Patel; Margaret M Billingsley; Caitlin Frazee; Xuexiang Han; Kelsey L Swingle; Jingya Qin; Mohamad-Gabriel Alameh; Karin Wang; Drew Weissman; Michael J Mitchell
Journal:  J Control Release       Date:  2022-05-23       Impact factor: 11.467

Review 2.  The notorious R.N.A. in the spotlight - drug or target for the treatment of disease.

Authors:  Philipp Reautschnig; Paul Vogel; Thorsten Stafforst
Journal:  RNA Biol       Date:  2016-07-14       Impact factor: 4.652

3.  Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureus.

Authors:  Julia Uebele; Christoph Stein; Minh-Thu Nguyen; Anja Schneider; Franziska Kleinert; Olga Tichá; Gabriele Bierbaum; Friedrich Götz; Isabelle Bekeredjian-Ding
Journal:  PLoS Pathog       Date:  2017-05-25       Impact factor: 6.823

Review 4.  mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2.

Authors:  Yingqi Jin; Chen Hou; Yonghao Li; Kang Zheng; Chuan Wang
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

5.  Preparation of Small RNAs Using Rolling Circle Transcription and Site-Specific RNA Disconnection.

Authors:  Xingyu Wang; Can Li; Xiaomeng Gao; Jing Wang; Xingguo Liang
Journal:  Mol Ther Nucleic Acids       Date:  2015-01-13       Impact factor: 10.183

Review 6.  Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread.

Authors:  Maireid B Bull; Carolyn A Cohen; Nancy H L Leung; Sophie A Valkenburg
Journal:  Viruses       Date:  2021-09-06       Impact factor: 5.048

7.  mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic.

Authors:  Peixian Chen; Xiaoye Shi; Weixin He; Guowei Zhong; Yan Tang; Hailin Wang; Peidong Zhang
Journal:  Hum Vaccin Immunother       Date:  2022-03-23       Impact factor: 3.452

Review 8.  Advances in COVID-19 mRNA vaccine development.

Authors:  Enyue Fang; Xiaohui Liu; Miao Li; Zelun Zhang; Lifang Song; Baiyu Zhu; Xiaohong Wu; Jingjing Liu; Danhua Zhao; Yuhua Li
Journal:  Signal Transduct Target Ther       Date:  2022-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.